PTSD in Cancer Patients: What Providers Need to Know
Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Multiple Myeloma
MULTIPLE MYELOMA ADVISOR
FEATURED CONTENT
-
-
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care. -
Current and Emerging Therapies for Relapsed and Refractory Multiple Myeloma
Experts review approved therapies and treatments still under investigation. -
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic. -
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
MULTIPLE MYELOMA NEWS
Qualitative Study Sheds Light on Patient Trust in Shared Decision Making in MM Treatment
Maintenance Daratumumab May Improve Outcomes vs Observation in Patients With Multiple Myeloma
Imaging Prior to Anti-CD38 Therapy Helps Predict Outcomes in Relapsed/Refractory Multiple Myeloma
Breakthrough COVID-19 May Be More Common in Patients With Lymphoid Malignancies
Combination Melflufen, Dexamethasone, Bortezomib Appears Safe in Patients With Multiple Myeloma
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Multiple Myeloma
Loading... 
Loading...